SOBR Safe, Inc. (SOBR) 10-K Summary: Fiscal Year Ended December 31, 2025
Business Context and Reporting Period
Company: SOBR Safe, Inc.
Reporting Period: Fiscal Year Ended December 31, 2025
Business Model: SOBR Safe develops and commercializes non-invasive personal alcohol awareness tracking devices (SOBRcheck and SOBRsure) integrated with the SOBRsafe software platform. The company targets behavioral wellness, workplace safety, and consumer markets.
Operational Status: The company is a smaller reporting company with a limited operating history, currently operating as a single segment. It relies on third-party manufacturers for its hardware devices.
Key Financial Metrics
| Metric | 2025 | 2024 |
|---|---|---|
| Revenue | $437,421 | $212,736 |
| Gross Profit | $235,501 | $19,168 |
| Gross Margin | 53.8% | 9.0% |
| Net Loss | $(8,951,121) | $(8,609,156) |
| Operating Cash Flow | $(6,957,967) | $(6,521,584) |
| Cash and Equivalents (End of Period) | $4,759,370 | $8,384,042 |
| Accumulated Deficit | $(107,330,252) | $(98,328,395) |
Liquidity: As of December 31, 2025, the company held approximately $4.76 million in cash. Management estimates a normalized monthly operating cash burn rate of approximately $580,000.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 105.6% year-over-year, driven by a 180.3% increase in SOBRsure device sales and a 384.8% increase in software subscription sales.
- Gross Margin Expansion: Gross margin improved significantly from 9.0% to 53.8%. This was primarily due to the disposal of first-generation inventory ($91,381) and damaged SOBRcheck devices ($24,360) in 2024. Adjusted for these one-time disposals, the 2024 margin was 63.4%, meaning the actual margin decreased 15.1% due to strategic price reductions and product replacement costs.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses increased 30.6% to $8.12 million, largely due to a comprehensive marketing plan and increased headcount. Research and development expenses decreased 55.9% as the company shifted focus from hardware development to software enhancements.
- Asset Impairment: The company recorded a non-cash asset impairment loss of $456,377 related to intangible assets in 2025, compared to none in 2024.
- Capital Raises: The company completed a 2025 PIPE Offering in December 2025, raising net proceeds of approximately $1.7 million. Additionally, warrant exercises in early 2025 generated approximately $3.6 million in net proceeds.
Guidance, Outlook, Risks, and Contingencies
- Going Concern: The company has incurred recurring losses and has an accumulated deficit exceeding $107 million. Management states that current cash balances do not provide adequate capital for the next twelve months. Substantial doubt exists regarding the company's ability to continue as a going concern without additional financing or significant revenue growth.
- Nasdaq Listing Risk: On March 19, 2026, the company received a deficiency letter from Nasdaq regarding its closing bid price remaining below the $1.00 minimum requirement for 30 consecutive days. Due to cumulative reverse stock splits (1-for-1100) over the last two years, the company is not eligible for the standard 180-day compliance period. The company has appealed and intends to submit a compliance plan, potentially involving another reverse stock split.
- Outlook: The company plans to expand into the broader health and wellness ecosystem, targeting behavioral health providers and retail consumers. It aims to leverage data analytics for insurance liability benchmarking.
- Key Risks:
- Dependence on third-party manufacturers and single-source suppliers.
- Need for additional capital to fund operations and product development.
- Market acceptance of innovative alcohol tracking technology.
- Intellectual property protection and potential litigation.
Investor Verification Checklist
- Cash Runway: Verify the sufficiency of the $4.76 million cash balance against the stated $580,000 monthly burn rate and the timeline for the next capital raise.
- Nasdaq Compliance: Monitor the outcome of the appeal regarding the bid price deficiency and the potential impact of a further reverse stock split on liquidity and shareholder value.
- Revenue Quality: Assess the sustainability of the 105% revenue growth and the impact of strategic price reductions on future gross margins.
- Going Concern Status: Review the specific plans management has implemented to alleviate the substantial doubt regarding the company's ability to continue operations.
- Warrant Dilution: Evaluate the dilutive impact of the 4.9 million outstanding warrants and the terms of the recent PIPE offerings.